JLK Inc (322510) - Net Assets
Based on the latest financial reports, JLK Inc (322510) has net assets worth ₩34.70 Billion KRW (≈ $23.52 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩69.51 Billion ≈ $47.10 Million USD) and total liabilities (₩34.80 Billion ≈ $23.58 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 322510 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩34.70 Billion |
| % of Total Assets | 49.93% |
| Annual Growth Rate | N/A |
| 5-Year Change | 71.74% |
| 10-Year Change | N/A |
| Growth Volatility | 200.23 |
JLK Inc - Net Assets Trend (2017–2025)
This chart illustrates how JLK Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see JLK Inc market capitalisation.
Annual Net Assets for JLK Inc (2017–2025)
The table below shows the annual net assets of JLK Inc from 2017 to 2025. Also explore JLK Inc net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩41.36 Billion ≈ $28.03 Million |
-16.13% |
| 2024-12-31 | ₩49.32 Billion ≈ $33.42 Million |
+320.61% |
| 2023-12-31 | ₩11.72 Billion ≈ $7.95 Million |
-29.45% |
| 2022-12-31 | ₩16.62 Billion ≈ $11.26 Million |
-31.00% |
| 2021-12-31 | ₩24.08 Billion ≈ $16.32 Million |
-21.47% |
| 2020-12-31 | ₩30.67 Billion ≈ $20.78 Million |
-15.51% |
| 2019-12-31 | ₩36.30 Billion ≈ $24.60 Million |
+495.57% |
| 2018-12-31 | ₩6.10 Billion ≈ $4.13 Million |
+170.51% |
| 2017-12-31 | ₩-8.64 Billion ≈ $-5.86 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to JLK Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7446950748000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩124.97 Billion | 302.16% |
| Total Equity | ₩41.36 Billion | 100.00% |
JLK Inc Competitors by Market Cap
The table below lists competitors of JLK Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kyongbo Pharmaceutical Co Ltd
KO:214390
|
$87.65 Million |
|
La Kaffa International Co Ltd
TWO:2732
|
$87.73 Million |
|
South Basic Chemicals JSC
VN:CSV
|
$87.74 Million |
|
Prozone Realty Limited
NSE:PROZONER
|
$87.75 Million |
|
Kyungdong City Gas Co Ltd
KO:267290
|
$87.62 Million |
|
Intech Biopharm Ltd
TWO:6461
|
$87.59 Million |
|
Toma as
PR:TOMA
|
$87.54 Million |
|
FitLife Brands, Inc. Common Stock
NASDAQ:FTLF
|
$87.52 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in JLK Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 49,312,281,570 to 41,359,507,840, a change of -7,952,773,730 (-16.1%).
- Net loss of 13,605,981,240 reduced equity.
- Other factors increased equity by 5,653,207,510.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-13.61 Billion | -32.9% |
| Other Changes | ₩5.65 Billion | +13.67% |
| Total Change | ₩- | -16.13% |
Book Value vs Market Value Analysis
This analysis compares JLK Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.08x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩-1728.76 | ₩5060.00 | x |
| 2018-12-31 | ₩554.11 | ₩5060.00 | x |
| 2019-12-31 | ₩2487.78 | ₩5060.00 | x |
| 2020-12-31 | ₩2077.52 | ₩5060.00 | x |
| 2021-12-31 | ₩1624.16 | ₩5060.00 | x |
| 2022-12-31 | ₩1107.88 | ₩5060.00 | x |
| 2023-12-31 | ₩740.54 | ₩5060.00 | x |
| 2024-12-31 | ₩1957.08 | ₩5060.00 | x |
| 2025-12-31 | ₩1641.99 | ₩5060.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently JLK Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -32.90%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -407.43%
- • Asset Turnover: 0.04x
- • Equity Multiplier: 1.80x
- Recent ROE (-32.90%) is above the historical average (-40.61%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 0.00% | -10002.02% | 0.02x | 0.00x | ₩-7.55 Billion |
| 2018 | -102.99% | -1729.70% | 0.04x | 1.55x | ₩-6.89 Billion |
| 2019 | -29.32% | -4637.28% | 0.01x | 1.07x | ₩-14.27 Billion |
| 2020 | -24.90% | -170.09% | 0.10x | 1.52x | ₩-10.70 Billion |
| 2021 | -31.45% | -200.05% | 0.09x | 1.68x | ₩-9.98 Billion |
| 2022 | -54.23% | -263.86% | 0.09x | 2.19x | ₩-10.67 Billion |
| 2023 | -62.45% | -294.23% | 0.08x | 2.83x | ₩-8.50 Billion |
| 2024 | -27.28% | -942.46% | 0.02x | 1.51x | ₩-18.38 Billion |
| 2025 | -32.90% | -407.43% | 0.04x | 1.80x | ₩-17.74 Billion |
Industry Comparison
This section compares JLK Inc's net assets metrics with peer companies in the Conglomerates industry.
Industry Context
- Industry: Conglomerates
- Average net assets among peers: $10,866,846,320,920
- Average return on equity (ROE) among peers: 3.70%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| JLK Inc (322510) | ₩34.70 Billion | 0.00% | 1.00x | $87.63 Million |
| Samyang Holdings (000070) | $779.17 Billion | 7.02% | 0.43x | $272.41 Million |
| Doosan Corp. (000150) | $8.90 Trillion | 0.73% | 2.52x | $13.34 Billion |
| Doosan Pref Shs (000155) | $8.90 Trillion | 0.73% | 2.52x | $1.10 Billion |
| Doosan Co Ltd (000157) | $6.82 Trillion | 6.16% | 3.28x | $211.35 Million |
| Hanwha (000880) | $5.89 Trillion | 9.43% | 12.09x | $6.23 Billion |
| Hanwha Corp. Pfd. Series 1 (000885) | $16.95 Trillion | 2.76% | 9.00x | $5.70 Million |
| Hanwha Corp Preferred (00088K) | $14.23 Trillion | 3.46% | 9.88x | $538.71 Million |
| CJ Corp (001040) | $11.99 Trillion | 3.87% | 1.45x | $2.34 Billion |
| Cj Corp Pref (001045) | $16.46 Trillion | 1.67% | 1.55x | $97.98 Million |
| CJ Corp 4P Pref (00104K) | $17.73 Trillion | 1.14% | 1.72x | $357.20 Million |
About JLK Inc
JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatme… Read more